Analysis of the Promoter Region of Human Dopamine Receptor D1

被引：2

作者：

Wu, Xue ^{[1
]}

Xu, Feng-ling ^{[1
]}

Wang, Bao-jie ^{[1
]}

Yao, Jun ^{[1
]}

机构：

[1] China Med Univ, Sch Forens Med, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China

来源：

JOURNAL OF MOLECULAR NEUROSCIENCE | 2018年 / 65卷 / 04期

基金：

中国国家自然科学基金;

关键词：

DRD1; Transcriptional regulator; Promoter; Neuropsychiatric disorder; GENE; SCHIZOPHRENIA; DRD1; POLYMORPHISMS; TRANSCRIPTION; ASSOCIATION; DEPENDENCE; DISORDER; DISEASE;

D O I：

10.1007/s12031-018-1116-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Dysregulation of dopamine receptor D1 (DRD1) is involved in multiple neuropsychiatric disorders. The 5' regulatory region of DRD1 has not been characterized fully. We applied the luciferase assay and the electrophoretic mobility shift assay to explore the activity of the 5' regulatory region of DRD1 in SH-SY5Y and 293T cells. We found that the promoter region of DRD1 corresponded to positions - 1250 to + 250 in the DNA sequence, and the putative core promoter region was from - 113 to + 250 (transcriptional start site of exon, +1). The sequence 5'-gggacgcgcgggcggggtgggctgtgccccgcgggaaccccgccggcctgtgcgcttgctg-3' was identified as a possible transcription factor-binding domain. Further research is warranted to explore the function of the 5' regulatory region of DRD1.

引用

下载

页码：438 / 443

页数：6

共 50 条

[41] Cloning of the feline renal dopamine D1 receptor
Edwards, HG
Rogers, CB
Wohl, JS
Kemppainen, RJ
Schwartz, DD
FASEB JOURNAL, 2005, 19 (04): : A111 - A111
[42] Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor
Blasiak, Ewa
Lukasiewicz, Sylwia
Szafran-Pilch, Kinga
Dziedzicka-Wasylewska, Marta
PHARMACOLOGICAL REPORTS, 2017, 69 (02) : 235 - 241
[43] Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor
Ewa Błasiak
Sylwia Łukasiewicz
Kinga Szafran-Pilch
Marta Dziedzicka-Wasylewska
Pharmacological Reports, 2017, 69 : 235 - 241
[44] POSTMORTEM STABILITY OF DOPAMINE D1 RECEPTOR MESSENGER-RNA AND D1 RECEPTORS
GILMORE, JH
LAWLER, CP
EATON, AM
MAILMAN, RB
MOLECULAR BRAIN RESEARCH, 1993, 18 (04): : 290 - 296
[45] The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors
Andringa, G
Drukarch, B
Leysen, JE
Cools, AR
Stoof, JC
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 364 (01) : 33 - 41
[46] Dopamine D1
Yang, Pengfei
Knight, William C.
Li, Huifangjie
Guo, Yingqiu
Perlmutter, Joel S.
Benzinger, Tammie L. S.
Morris, John C.
Xu, Jinbin
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (01): : 224 - 237
[47] Linkage analysis and molecular haplotyping of the dopamine D4 receptor gene promoter region
Szantai, E
Kiraly, O
Nemoda, Z
Kereszturi, E
Csapo, Z
Sasvari-Szekely, M
Gervai, J
Ronai, Z
PSYCHIATRIC GENETICS, 2005, 15 (04) : 259 - 270
[48] Modification of dopamine D1 receptor knockout phenotype in mice lacking both dopamine D1 and D3 receptors
Karasinska, JM
George, SR
El-Ghundi, M
Fletcher, PJ
O'Dowd, BF
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 399 (2-3) : 171 - 181
[49] Antagonist binding kinetics at the human D1 dopamine receptor determined by HTRF assay
Sengmany, Kathy
Wong, Ka-Wing
Charlton, Steven
Holliday, Nicholas
BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2525 - 2525
[50] Behavioral Effects of a Novel Allosteric Potentiator of the Dopamine D1 Receptor in Human D1 Knock-in Mice and Rhesus Monkeys
Svensson, Kjell A.
Beck, James P.
Hao, Junliang
Schaus, John M.
Maren, Deanna L.
Menezes, Michelle M.
Falcone, Julie F.
Anderson, Wesley
Knopp, Kelly
Adams, Benjamin L.
Witkin, Jeffrey M.
Li, Xia
Cramer, Jeffrey
Harper, Alex J.
Wafford, Keith A.
Zhang, Linli
Yang, Charles R.
Bruns, Robert F.
FASEB JOURNAL, 2016, 30

← 1 2 3 4 5 →